LON:AZN - AstraZeneca Stock Price, News, Headlines & Rumors Sign in or create an account to add this stock to your watchlist. Get Started GBX 5,936 -6.00 (-0.10 %) (As of 08/16/2018 04:00 PM ET)Previous CloseGBX 5,942Today's RangeGBX 5,896 - GBX 5,95452-Week RangeGBX 4,260 - GBX 5,520Volume1.97 million shsAverage Volume2.31 million shsMarket Capitalization£61.66 billionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileAnalyst RatingsChartDividend HistoryInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email AstraZeneca PLC discovers, develops, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, gastrointestinal, neuroscience, and infection diseases worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL4, Tenormin5, and Zestril6 for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo4 for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a strategic partnership with Bicycle Therapeutics. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom. Receive AZN News and Ratings via Email Sign-up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical SymbolLON:AZN CUSIPN/A Webwww.astrazeneca.com Phone+44-20-73045000 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins21.83% Return on Equity36.38% Return on Assets7.91% Miscellaneous EmployeesN/A Outstanding Shares1,270,000,000Market Cap£61.66 billion AstraZeneca (LON:AZN) Frequently Asked Questions What is AstraZeneca's stock symbol? AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN." How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca? AstraZeneca announced a dividend on Thursday, July 26th. Stockholders of record on Thursday, August 9th will be given a dividend of GBX 68.40 per share on Monday, September 10th. This represents a dividend yield of 1.19%. The ex-dividend date is Thursday, August 9th. The official announcement can be seen at this link. View AstraZeneca's Dividend History. What price target have analysts set for AZN? 23 brokerages have issued 12-month price targets for AstraZeneca's stock. Their forecasts range from GBX 4,080 to GBX 6,600. On average, they expect AstraZeneca's stock price to reach GBX 5,665.33 in the next twelve months. This suggests that the stock has a possible downside of 4.6%. View Analyst Price Targets for AstraZeneca. What is the consensus analysts' recommendation for AstraZeneca? 23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings, 7 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AstraZeneca. Who are some of AstraZeneca's key competitors? Some companies that are related to AstraZeneca include Sanofi (SAN), Bayer (BAYN), GlaxoSmithKline (GSK), BEXIMCO PHARMAC/S GDR REGS (BXP), OTSUKA HOLDINGS/ADR (OTSKY), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Sinclair Pharma (SPH), Pharmaxis (PXS) and NanoViricides (NNVC). Who are AstraZeneca's key executives? AstraZeneca's management team includes the folowing people: Mr. Pascal Soriot, Exec. Director & CEO (Age 59)Mr. Marc Dunoyer, Exec. Director & CFO (Age 66)Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 47)Mr. Jefrey Pott, Gen. CounselMs. Katarina Ageborg, Exec. VP of Sustainability & Chief Compliance Officer Has AstraZeneca been receiving favorable news coverage? Media coverage about AZN stock has been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group rates the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. AstraZeneca earned a news impact score of 0.20 on Accern's scale. They also assigned news stories about the biopharmaceutical company an impact score of 45.20 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View Recent Headlines for AstraZeneca. How do I buy shares of AstraZeneca? Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is AstraZeneca's stock price today? One share of AZN stock can currently be purchased for approximately GBX 5,936. How big of a company is AstraZeneca? AstraZeneca has a market capitalization of £61.66 billion. How can I contact AstraZeneca? AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000. MarketBeat Community Rating for AstraZeneca (LON AZN)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 1,214 (Vote Outperform)Underperform Votes: 1,431 (Vote Underperform)Total Votes: 2,645MarketBeat's community ratings are surveys of what our community members think about AstraZeneca and other stocks. Vote "Outperform" if you believe AZN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AZN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/16/2018 by MarketBeat.com StaffFeatured Article: What kind of dividend yield to CEF's pay?